New York, NY—Tomorrow, Friday, July 27, 2012, President Bill Clinton will address the closing session of the XIX International AIDS Conference at the Walter E. Washington Convention Center in Washington, D.C.
The speech will be open press.
The closing session is scheduled to begin at 3:15 PM EST. President Clinton will deliver remarks at 4:20 PM EST. Watch live at http://globalhealth.kff.org/aids2012/.
Friday, July 27, 2012
President Clinton Addresses XIX International AIDS Conference
4:20 PM EST
Walter E. Washington Convention Center
BACKGROUND ON HIV/AIDS & THE CLINTON HEALTH ACCESS INITIATIVE
The Clinton Health Access Initiative (CHAI) began in 2002 as the Clinton HIV/AIDS Initiative to address the HIV/AIDS crisis in the developing world and strengthen health systems there. Taking its lead from governments and working with partners, CHAI has improved markets for medicines and diagnostics, lowered the costs of treatment, and expanded access to life-saving technologies – creating a sustainable model that can be owned and maintained by governments. CHAI has since expanded this model to increase access to high-quality treatment for malaria, accelerate the rollout of new vaccines, and lower infant mortality. Today, more than 4 million people are benefiting from medicines purchased under CHAI agreements.
List of CHAI Accomplishments in HIV
- CHAI has reduced prices up to 90% for key HIV drugs and up to 80% for HIV diagnostics. Nearly four million people with HIV – 60% of all people being treated – are benefitting from these pricing agreements. Price reductions achieved between 2008 and 2011 will generate over $1 billion in savings over the next five years.
- CHAI helped to increase the number of HIV-positive children accessing treatment in 34 developing countries from approximately 10,000 in 2005 to approximately 340,000 at the end of 2011.
- CHAI negotiated 50-80% reductions in the price of CD4 tests from major suppliers that set the standard for CD4 pricing and test cost-savings in resource-limited countries where the majority of HIV patients live. In conjunction, CHAI provided wide ranging technical assistance in over 40 countries that contributed to the scale-up of CD4 testing and ART access.
- CHAI made three recent announcements:
- New antiretroviral price reductions, including a reduction in the price of preferred first line Tenofovir-based treatment will be available at $125 per patient per year, down from 69% in 2008; 30% from 2011. The Tenofovir price reduction alone will generate $530m of savings between now and 2015.
- Released results of costing study- Study across 161 treatment sites in 5 African countries shows that treatment costs at the facility level have come down dramatically and are now $200 per patient per year.
- Creation of Harbor-Path- a new organization that will manage pharmaceutical drug donations, acting as a one stop shop for uninsured Americans.